• Cash balance of €5.9 million (A$10.5m) at 30 September 2025
• Net cash outflow of €2.2 million during the quarter
• Delayed receipt of US$2.01 million customer renewal fee impacted Q3 results

Oneview Healthcare Plc released its Appendix 4C - Quarterly Cashflow report for the quarter ending 30 September 2025 (Q3 25) and provided an update on business activities. The Company's cash balance at 30 September 2025 was €5.9 million (A$10.5m) compared to €8.2 million (A$14.7m) at 30 June 2025. The Company had a net cash outflow of €2.2 million during the quarter compared to an outflow of €1.2 million in the same quarter of the prior year. Q3 25 was negatively impacted by the delayed receipt of an annual customer renewal fee of US$2.01 million (approximately €1.7m / A$3.1m) that was due in the quarter but not received until 21 October 2025. The Company maintained strong commercial momentum during the third quarter, adding a new customer, Kennedy Krieger, and expects to secure additional new customer logos before year-end. The Company deployed approximately 850 endpoints during Q3 2025 and is on track to exceed 15,000 total live endpoints by the end of 2025.

The Company maintained its solid commercial momentum and deployment progress during the third quarter of the year. Our strong U.S. pipeline of over 180 opportunities continues to deliver, with another new U.S. customer logo win and advanced contract negotiations underway with several prospects. We continued to make progress on improving deployment speed and efficiency, with 850 endpoints rolled out during the quarter. We look forward to closing out the year strongly by continuing the conversion of contracted endpoints to live, revenue-generating endpoints, while sustaining our commercial momentum through new customer acquisitions and account expansions to position the Company for continued growth into 2026.